Machine Learning-Enhanced Terahertz-Colorimetric Dual-Mode Metadevice Based on Metallic Nanonetworks for microRNA Panel Assays.
A machine-learning microRNA blood test detected all early pancreatic cancers in a small study, though larger validation is needed to confirm its real-world value.
This diagnostic assay development and validation study examined machine-learning classification of a multiplex microRNA liquid-biopsy assay for pancreatic cancer. The dual-mode assay reported diagnostic accuracy above 96 percent in both cohorts and detected all early pancreatic cancers in the small study.
What the study was
- Study design
- Diagnostic assay development and validation study
- Population
- 75 clinical samples across training and validation cohorts
- Sample size
- 75
- Category
- Early Detection
- Maturity
- Exploratory
- Journal
- ACS sensors
Why it surfaced
Retained as a high-priority diagnostic assay development and validation study after PubMed abstract review; the score reflects clinical relevance, design strength, novelty, and population need under the v1.3 conservative rubric.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.